Legislative Research: NJ A1526 | 2024-2025 | Regular Session

Other Sessions

SessionTitle/DescriptionLast Action
2024-2025
Regular Session

(Introduced)
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
[A1526 2024 Detail][A1526 2024 Text][A1526 2024 Comments]
2024-01-09
Introduced, Referred to Assembly Judiciary Committee
2022-2023
Regular Session

(Introduced - Dead)
Requires printers to display average cost per 1,000 printed pages and ink cartridges to display yield.
[A1526 2022 Detail][A1526 2022 Text][A1526 2022 Comments]
2022-01-11
Introduced, Referred to Assembly Consumer Affairs Committee
2020-2021
Regular Session

(Introduced - Dead)
Requires transportation network companies to provide riders with certain information and to issue illuminated identifying markers; requires MVC to create transportation network company driver database.
[A1526 2020 Detail][A1526 2020 Text][A1526 2020 Comments]
2020-01-14
Introduced, Referred to Assembly Transportation and Independent Authorities Committee
2018-2019
Regular Session

(Vetoed)
Concerns payment of independent contractors.*
[A1526 2018 Detail][A1526 2018 Text][A1526 2018 Comments]
2020-01-21
Pocket Veto - Bills not Acted on by Governor-end of Session
2016-2017
Regular Session

(Introduced - Dead)
Permits tax credit against gross income tax for certain adoption expenses.
[A1526 2016 Detail][A1526 2016 Text][A1526 2016 Comments]
2016-01-27
Introduced, Referred to Assembly Human Services Committee
2014-2015
Regular Session

(Introduced - Dead)
Requires all new State buildings to have solar or geothermal energy systems, where feasible.
[A1526 2014 Detail][A1526 2014 Text][A1526 2014 Comments]
2014-01-16
Introduced, Referred to Assembly Telecommunications and Utilities Committee
2012-2013
Regular Session

(Introduced - Dead)
Permits certain municipalities to purchase retail alcoholic beverage licenses regardless of population restrictions.
[A1526 2012 Detail][A1526 2012 Text][A1526 2012 Comments]
2012-01-10
Introduced, Referred to Assembly Law and Public Safety Committee
2010-2011
Regular Session

(Introduced - Dead)
Prohibits supplemental compensation for unused sick leave for public school and municipal employees with annual compensation of $100,000 or more.
[A1526 2010 Detail][A1526 2010 Text][A1526 2010 Comments]
2010-01-12
Introduced, Referred to Assembly Housing and Local Government Committee

References Online

Search PhraseWebNewsFinancialEncylopediaBiography
[New Jersey A1526]Google WebGoogle News
[New Jersey Assembly Judiciary Committee]Google WebGoogle NewsFollowTheMoney
[Representative Gerard Scharfenberger NJ]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart
[Representative Victoria Flynn NJ]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart

Legislative Citation

APA
NJ A1526 | 2024-2025 | Regular Session. (2024, January 09). LegiScan. Retrieved April 19, 2024, from https://legiscan.com/NJ/bill/A1526/2024
MLA
"NJ A1526 | 2024-2025 | Regular Session." LegiScan. LegiScan LLC, 09 Jan. 2024. Web. 19 Apr. 2024. <https://legiscan.com/NJ/bill/A1526/2024>.
Chicago
"NJ A1526 | 2024-2025 | Regular Session." January 09, 2024 LegiScan. Accessed April 19, 2024. https://legiscan.com/NJ/bill/A1526/2024.
Turabian
LegiScan. NJ A1526 | 2024-2025 | Regular Session. 09 January 2024. https://legiscan.com/NJ/bill/A1526/2024 (accessed April 19, 2024).

Subjects


Same As/Similar To

BillRelationshipDateTitleLast Action
A5448Carry Over2023-05-11Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.Introduced, Referred to Assembly Judiciary Committee
S3902Carry Over2023-06-01Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
S191Same As2024-01-09Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

New Jersey State Sources


feedback